ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W107. A total of 39 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 1.67 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $6,000 | -33.3% | 6,869 | 0.0% | 0.00% | – |
| Q3 2016 | $9,000 | -25.0% | 6,869 | 0.0% | 0.00% | – |
| Q2 2016 | $12,000 | +9.1% | 6,869 | +19.4% | 0.00% | – |
| Q1 2016 | $11,000 | -42.1% | 5,755 | 0.0% | 0.00% | – |
| Q4 2015 | $19,000 | +111.1% | 5,755 | +9.3% | 0.00% | – |
| Q3 2015 | $9,000 | -30.8% | 5,267 | +5.4% | 0.00% | – |
| Q2 2015 | $13,000 | -92.9% | 4,998 | -93.2% | 0.00% | – |
| Q1 2015 | $182,000 | -49.2% | 73,717 | +21.3% | 0.00% | – |
| Q4 2014 | $358,000 | -11.8% | 60,770 | +0.2% | 0.00% | -100.0% |
| Q3 2014 | $406,000 | +1.5% | 60,626 | +9.4% | 0.00% | 0.0% |
| Q2 2014 | $400,000 | – | 55,402 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 1,590,267 | $915,000 | 0.48% |
| ARMISTICE CAPITAL, LLC | 4,382,000 | $2,520,000 | 0.30% |
| DAFNA Capital Management LLC | 333,000 | $192,000 | 0.12% |
| SABBY MANAGEMENT, LLC | 2,434,103 | $1,400,000 | 0.09% |
| Anson Funds Management LP | 1,024,592 | $589,000 | 0.09% |
| Hartford Financial Management Inc. | 18,000 | $10,000 | 0.01% |
| Summit X, LLC | 11,000 | $7,000 | 0.01% |
| SNS Financial Group, LLC | 18,000 | $10,000 | 0.00% |
| DOWLING & YAHNKE LLC | 22,870 | $13,000 | 0.00% |
| A.R.T. Advisors, LLC | 30,005 | $17,000 | 0.00% |